Guangdong Hengrui Pharmaceutical Co., Ltd

This is the first study in humans to test the safety and early effects of an experimental drug called SHR-4712 for people with advanced solid tumors. The main goal is to find a safe dose and understand how the body processes the drug. Fifteen participants will receive the treatme…

This large Phase 3 study is testing whether an injectable medication called SHR-1819 can safely reduce symptoms in adults with moderate to severe atopic dermatitis (eczema). Researchers are comparing the drug against a placebo injection in 652 participants to see if it significan…